Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Nicotinamide and insulin sensitivity

  • 62 Accesses

  • 6 Citations

References

  1. 1.

    Chase P, Dupre J, Mahon JL et al. (1992) Nicotinamide and prevention of IDDM. Lancet 339: 1051 (Letter)

  2. 2.

    Kahn SE, Beard JC, Schwartz MW et al. (1989) Increased B-cell secretory capacity as mechanism for islet-adaptation to nicotinic-acid-induced insulin resistance. Diabetes 38: 562–568

  3. 3.

    Bergman RN, Beard J, Chen M (1986) Minimal modelling method. Assessment of insulin sensitivity and B-cell fraction in vivo. In: Clarke W, Lamer J, Pohl SL (eds) Methods in diabetes research: clinical methods. Vol 2. Wiley, Chichester New York Brisbane Toronto, pp 15–24

  4. 4.

    McKee RW, Kang-Lee YA, Panagua M, Swendseid NE (1982) Determination of nicotinamide and metabolic products in urine by high performance liquid chromatography. J Chromatogr 230: 309–317

  5. 5.

    Vague P, Picq R, Bernal M, Lassmann-Vague V, Vialettes B (1989) Effect of nicotinamide on the residual insulin secretion in type 1 (insulin-dependent) diabetes patients. Diabetologia 32: 316–321

  6. 6.

    Friedman LM, Furberg CD, DeMets DL (1985) Fundamentals of clinical trials. PSG Publishing Company, Littleton, p 96

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Paul, T.L. Nicotinamide and insulin sensitivity. Diabetologia 36, 369 (1993). https://doi.org/10.1007/BF00400244

Download citation

Keywords

  • Public Health
  • Internal Medicine
  • Human Physiology
  • Insulin Sensitivity
  • Metabolic Disease